• Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Outperform at Leerink Partners

    المصدر: Buzz FX / 06 نوفمبر 2024 06:56:16   America/Chicago


    Beam Therapeutics (NASDAQ:BEAM) Rating Increased to Outperform at Leerink Partners Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Beam Therapeutics ( NASDAQ:BEAM - Get Free Report ) was upgraded by Leerink Partners f
    Read more...
شارك على،